MacroGenics, Inc. is a company in the U.S. stock market and it is a holding in 38 U.S.-traded ETFs. MGNX has around 4.1M shares in the U.S. ETF market. The largest ETF holder of MGNX is the iShares Russell 2000 ETF (IWM), with approximately 1.05M shares. Investors may also find of interest that the ETF with the largest allocation to MGNX stock is Loncar Cancer Immunotherapy ETF (CNCR), with a portfolio weight of 2.08%. On average, U.S. ETFs allocate 0.13% of MGNX to their portfolios.
Additionally, MGNX is a favorite stock for Vanilla and Fundamental ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with MGNX as a holding is the ALPS Medical Breakthroughs ETF (SBIO), with a return of 19.89%.